Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/28/2007
 
Trade Name:  Ambien
 
Generic Name or Proper Name (*):  zolpidem
 
Indications Studied:  Insomnia associated with ADHD
 
Label Changes Summary:  Safety and effectiveness have not been established in pediatric patients with insomnia associated with ADHD In an 8-week controlled study in 201 pediatric patients 6-17 years, psychiatric and nervous system disorders comprised > 5% of treatment emergent adverse events, including dizziness (23.5%) headache (12.5%) and hallucinations (7.4%); treatment was discontinued due to an adverse event in 7.4%
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Sanofi Aventis
 
Pediatric Exclusivity Granted Date:  11/20/2006
 
NNPS:  FALSE'
 
Therapeutic Category:  Hypnotic
 
-
-